Enable Injections
Enable Injections develops and manufactures on-body delivery devices that allow patients to self-administer high-volume (up to 50 mL) and/or high-viscosity therapeutics. The company’s devices can be used to bring a new product to market, support lifecycle management (iv to sc; changes to dosing frequency), reduce overall healthcare costs (move from hospital to the home), or to increase product differentiation.
The Enable enFuse™ technology is a discreet body-worn device that provides a comfortable infusion experience allowing the patient to continue with normal daily activities. The Enable system is compatible with any standard container closure system, including a syringe or vial.
Enable Injections was founded in February 2010. It is privately held.